Below are the most recent publications written about "Alcoholism" by people in Profiles.
-
Cowan E, O'Brien-Lambert C, Eiting E, Bull E, Ryder J, Calderon Y, Salsitz E. Emergency department-initiated oral naltrexone for patients with moderate to severe alcohol use disorder: A pilot feasibility study. Acad Emerg Med. 2025 05; 32(5):488-497.
-
Quintanilla ME, Israel Y. Role of Metabolism on?Alcohol Preference, Addiction, and Treatment. Curr Top Behav Neurosci. 2025; 71:193-216.
-
Quintanilla ME, Santapau D, Diaz E, Valenzuela Martinez I, Medina N, Landskron G, Dominguez A, Morales P, Ram?rez D, Hermoso M, Olivares B, Berr?os-C?rcamo P, Ezquer M, Herrera-Marschitz M, Israel Y, Ezquer F. Intragastric administration of short chain fatty acids greatly reduces voluntary ethanol intake in rats. Sci Rep. 2024 11 26; 14(1):29260.
-
Noverati N, Mehta S, Reed MK, Zavodnick J. Understanding Barriers and Assessing Education Intervention on Prescribing Naltrexone for Alcohol Use Disorder. Am J Med Qual. 2024 Jul-Aug 01; 39(4):197-198.
-
Easley KF, Edenfield RC, Lott MEJ, Reed RC, Das Sarma J, Mehta AJ, Staitieh BS, Lipp EK, Cho IK, Johnson SK, Jones CA, Bebin-Blackwell AG, Levy JM, Tompkins SM, Easley CA, Koval M. Chronic alcohol use primes bronchial cells for altered inflammatory response and barrier dysfunction during SARS-CoV-2 infection. Am J Physiol Lung Cell Mol Physiol. 2023 11 01; 325(5):L647-L661.
-
Ayyala D, Bottyan T, Tien C, Pimienta M, Yoo J, Stager K, Gonzalez JL, Stolz A, Dodge JL, Terrault NA, Han H. Naltrexone for alcohol use disorder: Hepatic safety in patients with and without liver disease. Hepatol Commun. 2022 12; 6(12):3433-3442.
-
Sweeny L, Slijepcevic A, Curry JM, Philips R, Bonaventure CA, DiLeo M, Luginbuhl AJ, Crawley MB, Guice KM, McCreary E, Buncke M, Petrisor D, Wax MK. Factors Impacting Discharge Destination Following Head and Neck Microvascular Reconstruction. Laryngoscope. 2023 01; 133(1):95-104.
-
Ezquer F, Quintanilla ME, Morales P, Santapau D, Munita JM, Moya-Flores F, Ezquer M, Herrera-Marschitz M, Israel Y. A dual treatment blocks alcohol binge-drinking relapse: Microbiota as a new player. Drug Alcohol Depend. 2022 07 01; 236:109466.
-
Siegel SD, Brooks M, Ragozine-Bush HE, Schnoll RA, Curriero FC. The co-occurrence of smoking and alcohol use disorder in a hospital-based population: Applying a multimorbidity framework using geographic information system methods. Addict Behav. 2021 07; 118:106883.
-
Ezquer F, Quintanilla ME, Moya-Flores F, Morales P, Munita JM, Olivares B, Landskron G, Hermoso MA, Ezquer M, Herrera-Marschitz M, Israel Y. Innate gut microbiota predisposes to high alcohol consumption. Addict Biol. 2021 07; 26(4):e13018.